Anixa Biosciences Inc SEC filings ANIX

Anixa Biosciences Inc has 983 filings in SEC EDGAR's recent list, going back to Jun 9, 1995. Its latest annual report, Form 10-K, was filed on Jan 12, 2026 for the period ended Oct 31, 2025. The latest quarterly report (Form 10-Q) was filed on Sep 9, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Mar 11, 2026 (shareholder vote results, regulation fd disclosure). The company's fiscal year ends on October 31.

Form Description Filed Period
DEF 14A Proxy statement Jan 28, 2026 Jan 28, 2026
DEF 14A Proxy statement Feb 6, 2025 Oct 31, 2024
DEF 14A Proxy statement Feb 8, 2024 Feb 8, 2024
DEF 14A Proxy statement Jan 27, 2023 Jan 27, 2023
DEF 14A Proxy statement Jan 28, 2022 Jan 28, 2022
DEF 14A Proxy statement Apr 9, 2021 Apr 9, 2021
PRE 14A Preliminary proxy statement Mar 30, 2021 Mar 30, 2021
DEFA14A Additional proxy material Jul 20, 2020 —
DEF 14A Proxy statement Jul 2, 2020 Jul 2, 2020
PRE 14A Preliminary proxy statement Jun 22, 2020 Jun 22, 2020
DEF 14A Proxy statement Sep 12, 2019 Sep 12, 2019
DEF 14A Proxy statement Aug 17, 2018 Aug 17, 2018
DEF 14A Proxy statement Feb 12, 2018 Feb 12, 2018
PRE 14A Preliminary proxy statement Jan 26, 2018 Jan 26, 2018
DEF 14A Proxy statement Aug 8, 2017 Sep 22, 2017
DEFA14A Additional proxy material Jul 5, 2016 —
DEF 14A Proxy statement Jul 5, 2016 Aug 23, 2016
DEFA14A Additional proxy material Jul 16, 2015 —
DEF 14A Proxy statement Jul 16, 2015 Aug 26, 2015
DEFA14A Additional proxy material Jun 26, 2014 —
DEF 14A Proxy statement Jun 26, 2014 Aug 8, 2014
PRE 14A Preliminary proxy statement Jun 3, 2014 Jun 13, 2014
DEFA14A Additional proxy material Aug 27, 2013 —
DEF 14A Proxy statement Aug 27, 2013 Oct 11, 2013
PRE 14A Preliminary proxy statement Aug 12, 2013 Aug 12, 2013
DEFA14A Additional proxy material Nov 8, 2012 —
DEFA14A Additional proxy material Nov 6, 2012 —
DEFA14A Additional proxy material Oct 29, 2012 —
DEFA14A Additional proxy material Sep 24, 2012 —
DEFA14A Additional proxy material Sep 24, 2012 —
DEFA14A Additional proxy material Sep 21, 2012 —
DEF 14A Proxy statement Sep 21, 2012 Oct 31, 2012
PRE 14A Preliminary proxy statement Sep 10, 2012 Sep 10, 2012
DEF 14A Proxy statement Sep 23, 2011 Oct 26, 2011
DEF 14A Proxy statement Sep 27, 2010 Oct 26, 2010
DEF 14A Proxy statement Sep 23, 2009 Oct 29, 2009
DEF 14A Proxy statement Aug 4, 2008 Aug 28, 2008
DEF 14A Proxy statement Oct 3, 2006 Oct 31, 2006
DEF 14A Proxy statement Oct 7, 2005 Oct 31, 2005
DEF 14A Proxy statement Sep 30, 2004 Oct 28, 2004
DEF 14A Proxy statement Aug 8, 2002 Sep 12, 2002
DEF 14A Proxy statement Jul 17, 2001 Jul 17, 2001
DEF 14A Proxy statement Jun 12, 2000 Jul 25, 2000
DEF 14A Proxy statement Jun 28, 1999 Jul 28, 1999
DEF 14A Proxy statement Jun 29, 1998 Jul 29, 1998
DEF 14A Proxy statement Jun 23, 1997 Jul 23, 1997
PRE 14A Preliminary proxy statement Jun 9, 1997 Jul 23, 1997
DEF 14A Proxy statement Jun 24, 1996 Jul 24, 1996
DEF 14A Proxy statement Jun 14, 1995 Jul 19, 1995

Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ANIX (Nasdaq)
Fiscal year ends
October 31
Incorporated in
DE
Headquarters
San Jose, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
715446
Former names
ITUS Corp (until Sep 27, 2018); COPYTELE INC (until Aug 27, 2014)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.